HBM Healthcare Investments
Overview
HBM Healthcare Investments is a Swiss-based investment company that specializes in building and managing a globally diversified portfolio of private and public companies across the healthcare sector, including biotechnology, medical technology, diagnostics, and human medicine.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Principia | Aug 2018 | Series C | Lead |
| Everest Medicines | Jun 2020 | Series C | Co-investor |
| Valo Health | Nov 2021 | M&A | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is HBM Healthcare Investments based?
HBM Healthcare Investments is headquartered in Zug, Switzerland.
When was HBM Healthcare Investments founded?
HBM Healthcare Investments was founded in 2001.
How many portfolio companies does HBM Healthcare Investments have?
HBM Healthcare Investments has 55 portfolio companies in Caplight's dataset.
What are some companies in HBM Healthcare Investments's portfolio?
Portfolio companies visible on Caplight include Principia, Everest Medicines, Valo Health, Parabilis Medicines, Fog Pharmaceuticals.
What was HBM Healthcare Investments's most recent investment shown here?
HBM Healthcare Investments's most recent investment in this portfolio sample was in Parabilis Medicines in 2026.
What sectors does HBM Healthcare Investments focus on?
HBM Healthcare Investments focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce, Enterprise Software, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does HBM Healthcare Investments focus on?
HBM Healthcare Investments typically invests at the Mid stage.
What is HBM Healthcare Investments's AUM?
HBM Healthcare Investments's assets under management are estimated between $1.9B and $2.1B.